However, in our study, irrespective of body weight loss, Celastrol supplementation significantly increased AngII-induced AAA formation in both male and female Ldlr-/- mice, which suggests that Celastrol mediated AAA acceleration is independent of body weight reduction and possibly independent of SIRT1 induction. The gene discussed is LDLR; the disease is triple-A syndrome.